JP2022521266A5 - - Google Patents

Info

Publication number
JP2022521266A5
JP2022521266A5 JP2021549163A JP2021549163A JP2022521266A5 JP 2022521266 A5 JP2022521266 A5 JP 2022521266A5 JP 2021549163 A JP2021549163 A JP 2021549163A JP 2021549163 A JP2021549163 A JP 2021549163A JP 2022521266 A5 JP2022521266 A5 JP 2022521266A5
Authority
JP
Japan
Prior art keywords
seq
iapp peptide
iapp
nos
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021549163A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521266A (ja
JP7505713B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019557 external-priority patent/WO2020172686A1/en
Publication of JP2022521266A publication Critical patent/JP2022521266A/ja
Publication of JP2022521266A5 publication Critical patent/JP2022521266A5/ja
Priority to JP2024091172A priority Critical patent/JP7825238B2/ja
Application granted granted Critical
Publication of JP7505713B2 publication Critical patent/JP7505713B2/ja
Priority to JP2026021632A priority patent/JP2026094195A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549163A 2019-02-22 2020-02-24 アミロイドペプチドバリアント Active JP7505713B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024091172A JP7825238B2 (ja) 2019-02-22 2024-06-05 アミロイドペプチドバリアント
JP2026021632A JP2026094195A (ja) 2019-02-22 2026-02-13 アミロイドペプチドバリアント

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962809167P 2019-02-22 2019-02-22
US62/809,167 2019-02-22
PCT/US2020/019557 WO2020172686A1 (en) 2019-02-22 2020-02-24 Amyloid peptide variants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024091172A Division JP7825238B2 (ja) 2019-02-22 2024-06-05 アミロイドペプチドバリアント

Publications (3)

Publication Number Publication Date
JP2022521266A JP2022521266A (ja) 2022-04-06
JP2022521266A5 true JP2022521266A5 (cg-RX-API-DMAC7.html) 2022-11-14
JP7505713B2 JP7505713B2 (ja) 2024-06-25

Family

ID=72145021

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021549163A Active JP7505713B2 (ja) 2019-02-22 2020-02-24 アミロイドペプチドバリアント
JP2024091172A Active JP7825238B2 (ja) 2019-02-22 2024-06-05 アミロイドペプチドバリアント
JP2026021632A Pending JP2026094195A (ja) 2019-02-22 2026-02-13 アミロイドペプチドバリアント

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024091172A Active JP7825238B2 (ja) 2019-02-22 2024-06-05 アミロイドペプチドバリアント
JP2026021632A Pending JP2026094195A (ja) 2019-02-22 2026-02-13 アミロイドペプチドバリアント

Country Status (6)

Country Link
US (2) US12522635B2 (cg-RX-API-DMAC7.html)
EP (1) EP3927725A4 (cg-RX-API-DMAC7.html)
JP (3) JP7505713B2 (cg-RX-API-DMAC7.html)
CN (2) CN113614101B (cg-RX-API-DMAC7.html)
IL (1) IL285699A (cg-RX-API-DMAC7.html)
WO (1) WO2020172686A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4136446B1 (en) * 2020-05-19 2025-05-14 EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt Method for detecting amyloid aggregates in blood

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454299B (sv) * 1986-10-08 1988-04-18 Westermark P Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5814600A (en) 1991-05-24 1998-09-29 Amylin Pharmaceuticals Inc. Method and composition for treatment of insulin requiring mammals
US7060670B1 (en) 1999-05-05 2006-06-13 Neurochem (International) Limited Stereoselective antifibrillogenic peptides and peptidomimetics thereof
KR100994748B1 (ko) 2002-04-19 2010-11-17 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물
JP2007527365A (ja) 2003-03-18 2007-09-27 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ アミリン凝集阻害剤およびその使用
DE102004051014A1 (de) 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
GB0501348D0 (en) 2005-01-24 2005-03-02 Zyentia Ltd Compositions and methods
WO2007114838A1 (en) * 2006-03-31 2007-10-11 Amylin Pharmaceuticals, Inc. Amylin and amylin agonists for treating psychiatric diseases and disorders
EP2036923A1 (en) 2007-09-11 2009-03-18 Novo Nordisk A/S Improved derivates of amylin
BR112013007442A2 (pt) 2010-09-28 2019-09-24 Amylin Pharmaceuticals Llc polipeptídeos construídos tendo duração de ação realçada
US20130022620A1 (en) 2011-06-09 2013-01-24 Ann Marie Schmidt Assays and methods pertaining to pre-amyloid intermediates
EP2718315B1 (en) 2011-06-10 2017-12-27 Novo Nordisk A/S Pramlintide derivatives
JP6225189B2 (ja) 2012-09-12 2017-11-01 ニューリミューン ホールディング エイジー ヒト膵島アミロイドポリペプチド(hIAPP)特異的抗体およびその使用
WO2015062803A1 (en) 2013-10-29 2015-05-07 Kapurniotu Aphrodite Modified segments of islet amyloid polypeptide
CN108070075A (zh) 2016-11-09 2018-05-25 可口可乐公司 生物基meg和聚酯纤维组合物以及制造它们的方法
WO2018144671A1 (en) 2017-02-01 2018-08-09 The Research Foundation For The State University Of New York Mutant islet amyloid polypeptides with improved solubility and methods for using the same
EP3806884B1 (en) 2018-06-15 2023-08-02 Amyl Therapeutics General amyloid interaction motif (gaim)

Similar Documents

Publication Publication Date Title
JP2023002662A5 (cg-RX-API-DMAC7.html)
JP2024540183A5 (cg-RX-API-DMAC7.html)
AU2019334939B2 (en) Combination therapy for the treatment of liver disease
US9867816B2 (en) PPARγ agonists for treatment of multiple sclerosis
JP2019023202A (ja) Lsd1阻害剤を用いて多発性硬化症を処置する方法
JP2009544585A5 (cg-RX-API-DMAC7.html)
JP2022533968A5 (cg-RX-API-DMAC7.html)
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
CN101325964B (zh) Vip片段和应用方法
JP2023531675A5 (cg-RX-API-DMAC7.html)
JP2020536121A5 (cg-RX-API-DMAC7.html)
JP2020526525A5 (cg-RX-API-DMAC7.html)
JP2002511875A (ja) 勃起機能障害治療用のヨヒンビンおよびアルギニン含有薬
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
JP2004525940A5 (cg-RX-API-DMAC7.html)
JP2019507786A5 (cg-RX-API-DMAC7.html)
JP2022524576A5 (cg-RX-API-DMAC7.html)
JP2021512086A5 (cg-RX-API-DMAC7.html)
US3681497A (en) Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide
JP2021530568A5 (cg-RX-API-DMAC7.html)
JP2022543598A5 (cg-RX-API-DMAC7.html)
JP2021518392A5 (cg-RX-API-DMAC7.html)
JP2004529158A5 (cg-RX-API-DMAC7.html)
JP2023512487A5 (cg-RX-API-DMAC7.html)
CA2469702A1 (en) Darifenacin for use in the treatment of urgency induced by overactive bladder